131 related articles for article (PubMed ID: 38291576)
1. Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.
Warrior K; Sayad K; O'Hara CP; Dilling DF
Transplantation; 2024 Jun; 108(6):1460-1465. PubMed ID: 38291576
[TBL] [Abstract][Full Text] [Related]
2. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
4. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
6. Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need.
Schaffer JM; Singh SK; Reitz BA; Zamanian RT; Mallidi HR
JAMA; 2015 Mar; 313(9):936-48. PubMed ID: 25734735
[TBL] [Abstract][Full Text] [Related]
7. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: Long-term outcomes.
Bellier J; Lhommet P; Bonnette P; Puyo P; Le Guen M; Roux A; Parquin F; Chapelier A; Sage E;
Clin Transplant; 2019 Mar; 33(3):e13480. PubMed ID: 30657612
[TBL] [Abstract][Full Text] [Related]
9. Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.
ten Klooster L; Nossent GD; Kwakkel-van Erp JM; van Kessel DA; Oudijk EJ; van de Graaf EA; Luijk B; Hoek RA; van den Blink B; van Hal PT; Verschuuren EA; van der Bij W; van Moorsel CH; Grutters JC
Lung; 2015 Dec; 193(6):919-26. PubMed ID: 26404700
[TBL] [Abstract][Full Text] [Related]
10. Lung transplantation for high-risk patients with idiopathic pulmonary fibrosis.
De Oliveira NC; Julliard W; Osaki S; Maloney JD; Cornwell RD; Sonetti DA; Meyer KC
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):235-241. PubMed ID: 27758988
[TBL] [Abstract][Full Text] [Related]
11. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
Tanaka S; Miyoshi K; Higo H; Kurosaki T; Otani S; Sugimoto S; Yamane M; Kiura K; Toyooka S; Oto T
Respir Investig; 2019 Mar; 57(2):165-171. PubMed ID: 30600175
[TBL] [Abstract][Full Text] [Related]
12. Lung Transplantation in Idiopathic Pulmonary Fibrosis: Risk Factors and Outcome.
Amor MS; Rosengarten D; Shitenberg D; Pertzov B; Shostak Y; Kramer MR
Isr Med Assoc J; 2020 Dec; 22(12):741-746. PubMed ID: 33381944
[TBL] [Abstract][Full Text] [Related]
13. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
14. Bilateral versus single lung transplant for idiopathic pulmonary fibrosis.
Lehmann S; Uhlemann M; Leontyev S; Seeburger J; Garbade J; Merk DR; Bittner HB; Mohr FW
Exp Clin Transplant; 2014 Oct; 12(5):443-7. PubMed ID: 25299371
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.
Takahashi T; Terada Y; Pasque MK; Liu J; Byers DE; Witt CA; Nava RG; Puri V; Kozower BD; Meyers BF; Kreisel D; Patterson GA; Hachem RR
Chest; 2021 Nov; 160(5):1743-1750. PubMed ID: 34186034
[TBL] [Abstract][Full Text] [Related]
16. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
18. Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.
Courtwright AM; El-Chemaly S; Dellaripa PF; Goldberg HJ
J Heart Lung Transplant; 2017 Jul; 36(7):763-769. PubMed ID: 28131664
[TBL] [Abstract][Full Text] [Related]
19. Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
Tuyls S; Verleden SE; Wuyts WA; Yserbyt J; Vos R; Verleden GM
Transpl Int; 2019 Apr; 32(4):399-409. PubMed ID: 30488486
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
